Assenagon Asset Management S.A. Sells 28,935 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Assenagon Asset Management S.A. lowered its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 12.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 201,989 shares of the medical device company's stock after selling 28,935 shares during the period. Assenagon Asset Management S.A. owned about 0.10% of Cooper Companies worth $17,038,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of COO. OFI Invest Asset Management acquired a new stake in shares of Cooper Companies during the 4th quarter valued at about $34,000. City Holding Co. purchased a new stake in shares of Cooper Companies during the 1st quarter valued at approximately $34,000. New Age Alpha Advisors LLC purchased a new stake in shares of Cooper Companies during the fourth quarter worth $38,000. Covestor Ltd increased its position in shares of Cooper Companies by 35.5% during the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after acquiring an additional 120 shares during the period. Finally, Atala Financial Inc acquired a new position in shares of Cooper Companies during the fourth quarter worth $51,000. Institutional investors own 24.39% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on COO shares. Robert W. Baird decreased their price objective on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research note on Friday, May 30th. Stifel Nicolaus decreased their price target on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Wells Fargo & Company cut their target price on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a research note on Friday, May 30th. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Finally, Piper Sandler reaffirmed an "overweight" rating and issued a $105.00 price target (down from $115.00) on shares of Cooper Companies in a report on Friday, May 30th. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, Cooper Companies presently has a consensus rating of "Moderate Buy" and a consensus target price of $100.38.

Cooper Companies Price Performance

Shares of NASDAQ COO traded down $1.18 during trading on Friday, reaching $69.70. The company had a trading volume of 1,573,552 shares, compared to its average volume of 1,607,893. The Cooper Companies, Inc. has a 52 week low of $65.00 and a 52 week high of $112.38. The stock has a market cap of $13.94 billion, a PE ratio of 35.74, a PEG ratio of 2.25 and a beta of 0.98. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The business's 50 day moving average price is $77.93 and its 200-day moving average price is $86.37.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.03. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $1 billion during the quarter, compared to analysts' expectations of $995.12 million. During the same quarter in the prior year, the company earned $0.85 earnings per share. The business's quarterly revenue was up 6.3% compared to the same quarter last year. Analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.